Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma

Published:2024-06-05 Issue:24 Volume:9 Page:25945-25959
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Ahmed Sarfraz¹²,Queen Aarfa²³,Irfan Iram¹,Siddiqui Mohammad Naseem⁴,Abdulhameed Almuqdadi Haider Thaer¹⁵,Setia Nisha¹,Ansari Jaoud²^ORCID,Hussain Afzal⁶,Hassan Md. Imtaiyaz²^ORCID,Abid Mohammad¹^ORCID

Affiliation:

1. Medicinal Chemistry Laboratory, Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India

2. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India

3. Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

4. Department of Orthopaedics, Indira Gandhi Medical College & Hospital, Shimla, Himachal Pradesh 171001, India

5. Department of Chemistry, College of Science, Al-Nahrain University, Baghdad 10070, Iraq

6. Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia

Funder

Central Council for Research in Unani Medicine

Indian Council of Medical Research

University Grants Commission

Department of Science and Technology, Ministry of Science and Technology, India

King Saud University

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c00661

Reference55 articles.

1. MAPs, MARKs and microtubule dynamics

2. MARK4 Is a Novel Microtubule-associated Proteins/Microtubule Affinity-regulating Kinase That Binds to the Cellular Microtubule Network and to Centrosomes

3. A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma

4. Differential Signature of the Centrosomal MARK4 Isoforms in Glioma

5. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer’s disease treatment